Improvement in global cognition seen for patients with Alzheimer disease/MCI, but no effects seen for healthy individuals, other patient populations
Greater effect seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo
Proof-of-concept study is 'encouraging' for repurposing insomnia drug, authors say
Findings show importance of decomposing the traditional awareness score
In creating the database, the goal is to provide something that can 'improve applicability and generalizability of findings'
Later age at menopause and hormone therapy nonuse also associated with higher regional tau
Social isolation may be a modifiable risk factor for preventing Alzheimer disease-related dementias, authors say
Barriers to health care access and other socioeconomic factors may increase vulnerability in racial/ethnic minorities
Approval of Leqembi comes after controversial approval in 2021 of Aduhelm, which met with criticism over concerns about that drug's effectiveness, safety, pricing